1 reports of this reaction
2.9% of all SALICYLIC ACID 2% reports
#20 most reported adverse reaction
MIDDLE INSOMNIA is the #20 most commonly reported adverse reaction for SALICYLIC ACID 2%, manufactured by Guangzhou Huixue Biotechnology Co., Ltd.. There are 1 FDA adverse event reports linking SALICYLIC ACID 2% to MIDDLE INSOMNIA. This represents approximately 2.9% of all 35 adverse event reports for this drug.
Patients taking SALICYLIC ACID 2% who experience middle insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MIDDLE INSOMNIA is a less commonly reported adverse event for SALICYLIC ACID 2%, but still significant enough to appear in the safety profile.
In addition to middle insomnia, the following adverse reactions have been reported for SALICYLIC ACID 2%:
The following drugs have also been linked to middle insomnia in FDA adverse event reports:
MIDDLE INSOMNIA has been reported as an adverse event in 1 FDA reports for SALICYLIC ACID 2%. This does not prove causation, but indicates an association observed in post-market surveillance data.
MIDDLE INSOMNIA accounts for approximately 2.9% of all adverse event reports for SALICYLIC ACID 2%, making it a notable side effect.
If you experience middle insomnia while taking SALICYLIC ACID 2%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.